<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(7)</volume><submitter>Nakao K</submitter><pubmed_abstract>Background The JROAD-DPC (Japanese Registry of All Cardiac and Vascular Diseases Diagnosis Procedure Combination) is a nationwide claims database comprised of the Japanese DPC /Per Diem Payment System. This study aimed to investigate the relationship between prescription rates of guideline-directed medications in each hospital and in-hospital mortality among patients with acute myocardial infarction. Methods and Results A total of 61 838 Japanese patients from 741 hospitals with acute myocardial infarction between 2012 and 2013 were enrolled. The relationship between prescription rates of 4 guideline-directed medications for acute myocardial infarction and in-hospital mortality was analyzed. There were variations in the prescription ratio of β-blockers on admission (median prescription rate 23% [interquartile range 11% to 38%]) and at discharge (51% [36% to 63%]), and of angiotensin converting enzyme/receptor blocker (60% [47% to 70%]). The highest prescription rate quartile of each medication was associated with a significantly lower mortality compared with the lowest prescription rate quartile (aspirin on admission, incidence rate ratio 0.67 [95% CI 0.61-0.74], P&lt;0.001; aspirin at discharge, incidence rate ratio 0.50 [95% CI 0.46-0.55], P&lt;0.001; β-blocker on admission, 0.83 [0.76-0.92], P&lt;0.001; β-blocker at discharge, 0.78 [0.71-0.85], P&lt;0.001; angiotensin converting enzyme/receptor blocker, 0.68 [0.62-0.75], P&lt;0.001; statin, 0.63 [0.57-0.70], P&lt;0.001). The composite prescription score was inversely associated with in-hospital mortality (β coefficient=-0.48, P&lt;0.001) and was closer to the plateau in the high-score range (median mortality for composite prescription scores of 6, 15, and 24 were 10.6%, 6.8%, and 4.6%, respectively). Conclusions The prescription rates of guideline-directed medications for treatment of Japanese acute myocardial infarction patients were inversely associated with in-hospital mortality.</pubmed_abstract><journal>Journal of the American Heart Association</journal><pagination>e009692</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6509709</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Prescription Rates of Guideline-Directed Medications Are Associated With In-Hospital Mortality Among Japanese Patients With Acute Myocardial Infarction: A Report From JROAD - DPC Study.</pubmed_title><pmcid>PMC6509709</pmcid><pubmed_authors>Noguchi T</pubmed_authors><pubmed_authors>Komuro I</pubmed_authors><pubmed_authors>Nishimura K</pubmed_authors><pubmed_authors>Tsutsui H</pubmed_authors><pubmed_authors>Saito Y</pubmed_authors><pubmed_authors>Ogawa H</pubmed_authors><pubmed_authors>Anzai T</pubmed_authors><pubmed_authors>Nakao K</pubmed_authors><pubmed_authors>Shishido T</pubmed_authors><pubmed_authors>Nakai M</pubmed_authors><pubmed_authors>Ito H</pubmed_authors><pubmed_authors>Yasuda S</pubmed_authors><pubmed_authors>Miyamoto Y</pubmed_authors><pubmed_authors>Sumita Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prescription Rates of Guideline-Directed Medications Are Associated With In-Hospital Mortality Among Japanese Patients With Acute Myocardial Infarction: A Report From JROAD - DPC Study.</name><description>Background The JROAD-DPC (Japanese Registry of All Cardiac and Vascular Diseases Diagnosis Procedure Combination) is a nationwide claims database comprised of the Japanese DPC /Per Diem Payment System. This study aimed to investigate the relationship between prescription rates of guideline-directed medications in each hospital and in-hospital mortality among patients with acute myocardial infarction. Methods and Results A total of 61 838 Japanese patients from 741 hospitals with acute myocardial infarction between 2012 and 2013 were enrolled. The relationship between prescription rates of 4 guideline-directed medications for acute myocardial infarction and in-hospital mortality was analyzed. There were variations in the prescription ratio of β-blockers on admission (median prescription rate 23% [interquartile range 11% to 38%]) and at discharge (51% [36% to 63%]), and of angiotensin converting enzyme/receptor blocker (60% [47% to 70%]). The highest prescription rate quartile of each medication was associated with a significantly lower mortality compared with the lowest prescription rate quartile (aspirin on admission, incidence rate ratio 0.67 [95% CI 0.61-0.74], P&lt;0.001; aspirin at discharge, incidence rate ratio 0.50 [95% CI 0.46-0.55], P&lt;0.001; β-blocker on admission, 0.83 [0.76-0.92], P&lt;0.001; β-blocker at discharge, 0.78 [0.71-0.85], P&lt;0.001; angiotensin converting enzyme/receptor blocker, 0.68 [0.62-0.75], P&lt;0.001; statin, 0.63 [0.57-0.70], P&lt;0.001). The composite prescription score was inversely associated with in-hospital mortality (β coefficient=-0.48, P&lt;0.001) and was closer to the plateau in the high-score range (median mortality for composite prescription scores of 6, 15, and 24 were 10.6%, 6.8%, and 4.6%, respectively). Conclusions The prescription rates of guideline-directed medications for treatment of Japanese acute myocardial infarction patients were inversely associated with in-hospital mortality.</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Apr</publication><modification>2025-04-04T21:39:51.113Z</modification><creation>2019-06-06T23:29:44Z</creation></dates><accession>S-EPMC6509709</accession><cross_references><pubmed>30909774</pubmed><doi>10.1161/JAHA.118.009692</doi></cross_references></HashMap>